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Abstract
Burkholderia pseudomallei is a Gram-negative bacterium that infects macrophages and other cell types and causes
melioidosis. The interaction of B. pseudomallei with the inflammasome and the role of pyroptosis, IL-1b, and IL-18 during
melioidosis have not been investigated in detail. Here we show that the Nod-like receptors (NLR) NLRP3 and NLRC4
differentially regulate pyroptosis and production of IL-1b and IL-18 and are critical for inflammasome-mediated resistance to
melioidosis. In vitro production of IL-1b by macrophages or dendritic cells infected with B. pseudomallei was dependent on
NLRC4 and NLRP3 while pyroptosis required only NLRC4. Mice deficient in the inflammasome components ASC, caspase-1,
NLRC4, and NLRP3, were dramatically more susceptible to lung infection with B. pseudomallei than WT mice. The
heightened susceptibility of Nlrp3
-/- mice was due to decreased production of IL-18 and IL-1b. In contrast, Nlrc4
-/- mice
produced IL-1b and IL-18 in higher amount than WT mice and their high susceptibility was due to decreased pyroptosis and
consequently higher bacterial burdens. Analyses of IL-18-deficient mice revealed that IL-18 is essential for survival primarily
because of its ability to induce IFNc production. In contrast, studies using IL-1RI-deficient mice or WT mice treated with
either IL-1b or IL-1 receptor agonist revealed that IL-1b has deleterious effects during melioidosis. The detrimental role of IL-
1b appeared to be due, in part, to excessive recruitment of neutrophils to the lung. Because neutrophils do not express
NLRC4 and therefore fail to undergo pyroptosis, they may be permissive to B. pseudomallei intracellular growth.
Administration of neutrophil-recruitment inhibitors IL-1ra or the CXCR2 neutrophil chemokine receptor antagonist
antileukinate protected Nlrc4
-/- mice from lethal doses of B. pseudomallei and decreased systemic dissemination of bacteria.
Thus, the NLRP3 and NLRC4 inflammasomes have non-redundant protective roles in melioidosis: NLRC4 regulates
pyroptosis while NLRP3 regulates production of protective IL-18 and deleterious IL-1b.
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Introduction
The ability to detect infection by pathogenic microbes and to
restrict their growth are fundamental for the wellbeing of
multicellular organisms. Pattern recognition receptors, including
the Toll-like receptor (TLR) and the NLR, recognize microbial
products and ‘‘danger signals’’ released by stressed cells and, in
turn, activate signaling pathways that initiate the inflammatory
response and regulate development of adaptive immunity. TLR
are expressed on the cell surface or in endosomal compartments
and their stimulation results in activation of the NF-kB, MAPK,
and IRF signaling pathways culminating in transcriptional
induction of a large number of genes. NLR, in contrast, are
located in the cytoplasm, which they survey for evidence of danger
or infection (reviewed in ref. [1]). Some NLR control activation of
the inflammasome, a multiprotein complex that contains, in
addition to a NLR, the adaptor molecule ASC and the protease
caspase-1. Activation of caspase-1 in the context of the inflamma-
some is responsible for the proteolytic processing of the immature
forms of IL-1b and IL-18, a modification required for the secretion
and bio-activity of these proinflammatory cytokines. Activation of
caspase-1 also triggers a form of cell death, known as pyroptosis,
that effectively restricts intracellular bacterial growth [2,3].
Production of IL-1b and IL-18 and induction of pyroptosis have
been shown to be protective effector mechanisms against many
infectious agents. NLRP3 and NLRC4 are the best characterized
NLR molecules. NLRP3 controls caspase-1 activation in response
to ‘‘danger signals’’, several particles and crystals, and various
bacteria, virus, and fungi. Although the logic that oversees the
activation of the NLRP3 inflammasome is still elusive, it appears
that disruption of cell membrane integrity may be a common
event triggered by the NLRP3 activators. The NLRC4 inflamma-
some is responsive to a narrower spectrum of activators including
cytoplasmically delivered bacterial flagellin and the basal rod
constituent of various bacterial Type III secretion systems (T3SS).
The T3SS apparatus is used by several bacteria, including
Salmonella, Yersinia, Pseudomonas, Shigella, Legionella, and Burkholderia
to inject virulence factors into the cytoplasm of target cells. Recent
PLoS Pathogens | www.plospathogens.org 1 December 2011 | Volume 7 | Issue 12 | e1002452works demonstrated that the specificity of the mouse NLRC4 for
flagellin or rod proteins is determined by its interaction with the
NLR molecules NAIP5 or NAIP2, respectively [4,5].
Burkholderia pseudomallei is a Gram-negative flagellate bacterium
that causes melioidosis, a disease endemic to South-East Asia and
other tropical regions [6,7] and the most common cause of
pneumonia-derived sepsis in Thailand. Because melioidosis carries
a high fatality rate, B. pseudomallei is classified as category B
potential bioterrorism agent by the Center for Disease Control and
NIAID. B. pseudomallei infection can be contracted through
ingestion, inhalation, or subcutaneous inoculation and leads to
broad-spectrum disease forms including pneumonia, septicemia,
and organ abscesses. Following infection of macrophages and
other non-phagocytic cell types, B. pseudomallei is able to escape the
phagosome and invade and replicate in the host cell cytoplasm,
directly spreading from cell to cell using actin-tail propulsion.
Macrophages and IFNc have been shown to play a critical role in
protection from melioidosis [8–10] and several B. pseudomallei
virulence factors have been identified including the bacterial
capsule [11], the lipopolysaccharide [12], and one of the three
T3SS possessed by B. pseudomallei [13]. Analysis of mouse strains
with different susceptibility to B. pseudomallei infection indicates that
the early phases of the infection are crucial for survival [14,15],
emphasizing the necessity for better understanding of innate
immune responses during melioidosis. With this goal in mind,
using a murine model of melioidosis we have performed a detailed
analysis of the role of the inflammasome components NLRP3,
NLRC4, ASC, and caspase-1 and the effector mechanisms IL-1b,
IL-18, and pyroptosis.
Results
NLRP3 and NLRC4 differentially regulate production of IL-
1b and pyroptosis
To identify the pathway responsible for IL-1b and IL-18
secretion in response to infection with B. pseudomallei, bone
marrow-derived macrophages (BMDM) or dendritic cells (BMDC)
derived from WT mice or mice deficient in the inflammasome
components ASC, NLRP3, NLRC4, or caspase-1 were infected in
vitro with B. pseudomallei and secretion of IL-1b in culture




-/- BMDM was markedly
reduced compared to WT BMDM. Production of IL-1b during
the first hours of the infection was also significantly reduced in
Nlrc4
-/- cells. However, later in the infection process (8 hours)
Nlrc4
-/- cells secreted IL-1b at levels considerably higher than WT
cells. Secretion of IL-18 followed a similar pattern (data not
shown). Immunoblotting of the supernatants confirmed processing
of IL-1b and of caspase-1 to the mature 17 kDa and p20 forms,
respectively (figure 1B). Interestingly, although caspase-1 was
activated in Asc
-/- cells, processing and secretion of IL-1b was not
observed. NLRC4 possesses an amino-terminal CARD domain
that can recruit and activate caspase-1 independently of ASC. It is
unclear at present why activation of caspase-1 in Asc
-/- cells is not
sufficient to trigger secretion of mature IL-1b, a phenomenon
previously reported by other groups [16]. The differences in IL-1b
and IL-18 secretion were observed regardless of the number of
bacteria used to infect cells (MOI 10, 50, or 100, data not shown)
and were not due to differential induction of pro-IL-1b, which was
present at comparable amounts in all the cell lysates. Thus, the
NLRC4 and NLRP3 inflammasomes are both mediating release
of IL-1b and IL-18 by myeloid cells infected with B. pseudomallei.
Inflammasome-mediated induction of pyroptosis has been
demonstrated to be a mechanism that restricts growth of certain
intracellular bacteria [2,3]. To measure induction of pyroptosis in
cells infected with B. pseudomallei we used a kanamycin protection
assay that allows only replication of intracellular bacteria whereas
cells that undergo pyroptosis expose the bacteria to the
microbicidal action of the antibiotic present in the medium.
Induction of pyroptosis and intracellular bacterial replication were
measured in WT or inflammasome-deficient BMDM infected with
B. pseudomallei. As shown in figure 1C (upper graph), pyroptosis of
infected cells (as measured by release of LDH in culture
supernatants) was significantly reduced in Casp1
-/- and Nlrc4
-/-
cells compared to WT and Nlrp3
-/-. Importantly, induction of
pyroptosis was not lost in Asc
-/- cells. NLRC4-mediated pyroptosis
induced by other bacteria is also reported to be ASC-independent
[16–19]. Consistent with the role of pyroptosis as a mechanism to
restrict intracellular bacteria growth, considerably less intracellular





-/- cells at all time points (figure 1C, lower graph).
Similar results regarding IL-1b processing and secretion and
induction of pyroptosis were obtained using BMDC derived from
the inflammasome–deficient mice (supplementary figure S1).
Taken together these results show that infection of macrophages
and dendritic cells with B. pseudomallei leads to activation of the
NLRC4 and NLRP3 inflammasomes. NLRC4 contributes to IL-
1b during the early phase of the infection and induction of
pyroptosis that restricts bacterial growth. NLRP3 does not control
pyroptosis and primarily controls IL-1b secretion. It should be
noted that the defective IL-1b production of Nlrc4
-/- and Nlrp3
-/-
cells cannot be ascribed to the difference in induction of
pyroptosis: thus Nlrp3
-/- cells produce less cytokine than WT cells
despite undergoing pyroptosis to the same extent as WT cells.
Conversely, Nlrc4
-/- cells, which are resistant to pyroptosis, still
produce less cytokine than WT cells at the early time point.
However, at later time points Nlrc4
-/- cells produce considerably
more IL-1b than WT cells. This is likely due to the fact that WT
cells rapidly die after infection while Nlrc4
-/- cells remain viable
and continue to synthesize and secrete IL-1b.
Author Summary
The disease melioidosis is caused by the intracellular
bacterium Burkholderia pseudomallei, a potential bioterror-
ism agent. Here we examined the interaction of B.
pseudomallei with the inflammasome, an important innate
immune pathway that regulates at least two host
responses protective against infections: 1) secretion of
the proinflammatory cytokines IL-1b and IL-18 and 2)
induction of pyroptosis, a form of cell death that restricts
intracellular bacteria growth. Using a mouse model of
melioidosis we show that two distinct inflammasomes are
activated by B. pseudomallei infection. One, containing the
Nod-like receptor (NLR) NLRP3, mediates IL-1b and IL-18
induction. The other contains a different NLR called NLRC4
and mediates pyroptosis. Pyroptosis and IL-18 production
were equally important for resistance to B. pseudomallei.
Surprisingly, IL-1b was found to be deleterious in
melioidosis. The detrimental role of IL-1b during melioi-
dosis was due, in part, to excessive recruitment of
neutrophils to the lung. We show that neutrophils do
not express NLRC4, fail to undergo pyroptosis, and,
therefore, may be permissive to B. pseudomallei intracel-
lular replication leading to increased bacterial burden and
morbidity/mortality. Thus, the NLRP3 and NLRC4 inflam-
masomes have non-redundant protective roles in melioi-
dosis: NLRC4 regulates pyroptosis while NLRP3 regulates
production of protective IL-18 and deleterious IL-1b.
Role of Pyroptosis, IL-18 and IL-1b in Melioidosis
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The role of the inflammasome during in vivo B. pseudomallei
infection was next analyzed using a mouse model of melioidosis
(figure 2). WT mice or inflammasome-deficient mice were infected
intranasally with B. pseudomallei (100 CFU) and their weight (not
shown) and survival were monitored (figure 2A). All mice started to
lose weight 2 days post-infection. Generally, mice that survived the




-/- mice were extremely susceptible to melioidosis
compared to WT mice. Nlrp3
-/- mice were also considerably more
susceptible than WT mice but slightly more resistant than the
other inflammasome deficient mice. Measurement of the bacterial
burdens in lungs, spleens, and livers of infected mice 24 hours
(data not shown) and 48 hours post-infection revealed that Nlrc4
-/-
and Casp1
-/- mice carried considerably higher burdens in all three
organs than WT mice (figure 2B). Surprisingly, the bacterial
burden of Asc
-/- and Nlrp3
-/- mice was not significantly different
from that of WT mice at the tested time points despite their higher
mortality.
Cytokine levels were measured in bronchio-alveolar lavage
fluids (BALF) obtained from infected mice (figure 2C). Confirming




-/- mice. In contrast, IL-1b and IL-18
were present in the lungs of Nlrc4
-/- mice in amounts considerably
higher than WT mice. Immunoblotting experiments confirmed
that the IL-1b measured by ELISA was in fact the p17 mature
form of IL-1b (figure 2D). Thus, although the in vitro experiments
demonstrated that both the NLRP3 and the NLRC4 inflamma-
some contribute to IL-1b and IL-18 production in response to B.
pseudomallei infection, it is the NLRP3 inflammasome that primarily
mediates production of these cytokines in vivo. The levels of several
other proinflammatory cytokines, including IL-1a (figure S2), were
significantly elevated in Nlrc4
-/- BALF. It is interesting to note that
the levels of IL-18 in BALF of Asc
-/- and Casp1
-/- mice, although
very low, were higher than uninfected mice suggesting the
existence of inflammasome-independent mechanisms to produce
IL-1b and IL-18, as it has been previously shown in models of
highly neutrophilic inflammation [20-23].
Histological analysis of the infected lungs revealed extensive
inflammatory cell infiltration in the lung parenchyma (data not
shown). The area of the inflammatory nodules, relative to the total
area of the lung lobe, was calculated for each given section and
found to be significantly greater in Nlrc4
-/- mice compared to WT
mice (figure 2E). This result was consistent with the elevated levels
of inflammatory cytokines and chemokines produced by Nlrc4
-/-
mice. Taken together these results suggest a scenario where failure
of Nlrc4
-/- infected macrophages to undergo pyroptosis results in
higher bacterial burden and continued production of IL-1b and
other factors that attract more inflammatory cells, perpetuating
lung inflammation and promoting bacteria dissemination.
Thus, our results identified two distinct infammasome-mediated
mechanisms that efficiently restrict B. pseudomallei growth and
pathogenesis: production of the cytokines IL-1b and IL-18 and
induction of pyroptosis. The high susceptibility of Nlrp3
-/- and
Asc
-/- mice to meliodiosis is due to defective cytokine production
while that of the Nlrc4
-/- mice likely results from defective
pyroptosis. Casp1
-/- mice are impaired in both inflammasome
effector mechanisms and, therefore, we predicted that they would
Figure 1. NLRP3 and NLRC4 differentially regulate production of IL-1b and pyroptosis. BMDM were infected with B. pseudomallei at MOI
of 10. (A) Secretion of mature IL-1b was measured in conditioned supernatants of infected and uninfected cells at the indicated times. (B) Processing
of IL-1b and caspase-1 was detected by immunoblot in 8 h conditioned supernatants from A. Pro-IL-1b was detected in cell lysate of the infected
cells. (C) Induction of pyroptosis was measured as LDH release in conditioned supernatants of infected BMDM (MOI 10) (upper panel). Infected BMDM
were lysed at the indicated time points after infection and intracellular bacteria growth was quantitated (lower panel). One experiment representative
of three is shown. *p,0.05, **p,0.01, ***p,0.001 (1way ANOVA).
doi:10.1371/journal.ppat.1002452.g001
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double knock-out mice (DKO) (that are defective in cytokines but
retain pyroptosis) or Nlrc4
-/- mice (that retain IL-1b/IL-18
functionality but are deficient in pyroptosis). This prediction was
found to be correct. As shown in figure 2F, when mice were
infected with only 25 CFU (a non-lethal dose for WT mice) the
mean time to death of Nlrc4
-/- and Il-1r1
-/--Il-18
-/- DKO mice was
slightly but significantly (p,0.05, Kaplan-Meier test) increased
compared to Casp1
-/- mice. Surprisingly, Asc
-/- mice, which should
be equivalent to DKO because of the absence of IL-1b or IL-18,
survived the infection. This may be explained by the observation
that IL-18, although drastically reduced, it is still detectable in
Asc
-/- mice at higher level than uninfected mice (figure 2C).
Role of IL-18 and IL-1b in murine melioidosis
We next analyzed the role of the inflammasome-dependent
cytokines IL-1b and IL-18 during murine melioidosis. IL-18-
deficient mice were extremely susceptible to B. pseudomallei
infection even when infected with 25 CFU, a dose of bacteria
that caused no mortality and only mild weight loss in WT mice
(figure 3A). In contrast, Il-1r1
-/- mice displayed increased
resistance to B. pseudomallei infection compared to WT mice
(figure 3A and see below). The survival of mice deficient in both
IL-18 and IL-1RI (DKO) was indistinguishable from the Il-18
-/-
mice when the animals were infected with 100 CFU. However, in
DKO mice infected with 25 CFU (figure 3A, right panel) the
concomitant absence of IL-18 and IL-1RI provided a significant
advantage over Il-18
-/- mice (p,0.05) suggesting a detrimental
role of IL-1RI-mediated signaling in melioidosis (see below).
Confirming the different susceptibilities of Il-18
-/- and Il-1r1
-/-
mice to melioidosis, the bacterial burdens observed in the lungs,
spleens, livers, and BALF of infected Il-18
-/- mice were dramatically
higherthanthat ofWTmiceeven at earlytime points(24hours post
infection, figure 3B). In contrast, significantly lower amounts of
bacteria were recovered 48 hours post infection from Il-1r1
-/- mice
compared to WT mice confirming their higher resistance.
Measurements of cytokines in the BALF obtained from mice at
24 and 48 hours post-infection (figure 3C) indicated that the levels
of IFNc were drastically reduced in Il-18
-/- mice, a finding
consistent with the established function of IL-18 as an IFNc-
inducing cytokine. Remarkably, IFNc levels in Il-1r1
-/- mice were
greatly increased compared to WT mice. The levels of the
neutrophil attractants Mip-2, KC, and IL-17 were also decreased
in Il-1r1
-/- mice and increased in Il-18
-/- mice (figure S2). The
number of inflammatory cells recovered from the BALF of
infected Il-1r1
-/- mice was significantly decreased compared to
WT mice (see figure 4B, left panel). Histological analysis of the
infected lungs revealed extensive inflammatory cell infiltration in
the lung parenchyma of Il-18
-/- mice (see figure 4C). The area of
the inflammatory nodules, relative to the total area of the lung
lobe, was calculated for each given section and found to be
significantly greater in Il-18
-/- mice compared to WT mice
(figure 4D).
Considering that IFNc is known to play a protective role during
several bacterial infections, including B. pseudomallei [8–10], these
results suggested that the reduced resistance of Il-18
-/- mice to B.
pseudomallei infection may be due to lack of IFNc induction. To test
this hypothesis, a group of Il-18
-/- mice infected with B. pseudomallei
were given daily intraperitoneal injections of either recombinant
IFNc or PBS. As shown in figure 3D, exogenous IFNc completely
protected the mice suggesting that IL-18 exerts its protective
action primarily through induction of IFNc.
Deleterious role of IL-1b in melioidosis
The results of figure 3 showed that Il-1r1
-/- mice were more
resistant to lung infection with B. pseudomallei. This appeared even
Figure 2. Differential contributions of NLRP3 and NLRC4 to melioidosis. (A) Mice were intranasally infected with B. pseudomallei (100 CFU)
and their survival was monitored. *p,0.05 (Kaplan-Meier), WT compared to other genotypes (B) Mice were sacrificed 48 hours post-infection and the
bacterial burdens were measured in organ homogenates. (C) Cytokines were measured in BALF obtained 48 hours post-infection. (D) Processing of IL-
1b was detected by immunoblot in BALF from C. (E) Lung sections were stained with H&E and the total area of the inflammatory nodules was
measured and expressed as percentage of the total lung lobe area. *p,0.05, **p,0.01, ***p,0.001 (1way ANOVA). (F) Mice were intranasaly infected
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pseudomallei that killed all WT mice but only a fraction of the Il-
1r1
-/- mice (figure 4A). Recruitment of neutrophils, macrophages,
and dendritic cells into alveolar spaces was decreased in Il-1r1
-/-
mice compared to WT mice (figure 4B, left graph). Lower levels of
the neutrophil enzyme myeloperoxidase (MPO) were detected in
the BALF of Il-1r1
-/- mice compared to WT (figure S3). The
extent of lung inflammation, as measured by the number and size
of inflammatory nodules, was also significantly decreased in Il-
1r1
-/- mice (figure 4C, and 4D).
To further test the hypothesis that IL-1R-mediated signaling has
a deleterious role in this model of melioidosis, WT mice were
infected with 100 CFU B. pseudomallei and were given daily
intraperitoneal injections of IL-1b or PBS (figure 4E). All mice that
received the cytokine succumbed to the infection compared to
significantly higher survival of the control group. Injection of IL-
1b in non-infected mice had no deleterious effect aside from a
transient, negligible weight loss (not shown). The bacteria burdens
in organs of IL-1b-treated mice 72 hours post infection were
dramatically higher than the control group and bacteremia was
detected in IL-1b-treated mice but not control mice (figure 4F).
Higher number of neutrophils, macrophages, and dendritic cells
were found in the BALF of IL-1b-treated mice (figure 4B, center
graph). This correlated with increased level of MPO in BALF
(figure S3). The increased inflammatory cell recruitment to the
lungs of IL-1b-treated mice was likely due to the induction, by IL-
1b, of neutrophil chemoattractans KC (CXCL1) and MIP-2
(CXCL-2), which in fact were detected at very high levels in the
BALF of IL-1b-treated mice (figure S2). Histological analysis of
lung sections of mice treated with IL-1b showed a dramatic
increase in the number and size of the foci of infiltrating
inflammatory cells (figure 4C, lower left panels) and evidence of
perivascular edema and airway obstruction (figure 4C, lower right
panels).
If IL-1b in fact has a detrimental effect during melioidosis,
inhibition of its activity should lower morbidity and mortality of
mice infected with B. pseudomallei. As shown in figure 4G,
administration of the IL-1 receptor antagonist IL-1ra protected
mice from infection with lethal doses of B. pseudomallei. Mice
treated with IL-1ra had decreased recruitment of inflammatory
cells to the alveolar spaces (figure 4B, right graph) lower level of
MPO in BALF (figure S3), and less severe lung pathology (data not
shown).
Neutrophils fail to restrict B. pseudomallei intracellular
growth and are resistant to pyroptosis
Surprisingly, in our experiments lower numbers of neutrophils
in Il-1r1
-/- mice correlated with lower bacterial burdens while IL-
1b administration resulted in increased neutrophil recruitment but
also increased bacterial burdens and systemic dissemination. These
results would be consistent with the notion that neutrophils are not
very effective at containing B. pseudomallei infection and, in fact,
may foster its spread. In support of this idea, human neutrophils
infected with B. pseudomallei underwent pyroptosis at a much slower
rate than infected monocytes (figure 5A). Concomitantly, intra-
Figure 3. Differential contributions of IL-1 and IL-18 to melioidosis. (A) Mice were intranasaly infected with B. pseudomallei (100 CFU, left, or
25 CFU, right) and their survival was monitored. *p,0.05, **p,0.01 (Kaplan-Meier), WT compared to other genotypes (left), Il-18
-/- compared to DKO
(right). (B, C) Mice infected with B. pseudomallei (100 CFU) were sacrificed 24 hours or 48 hours postinfection and the bacterial burdens in organ
homogenates and BALF (B) or cytokines levels in BALF (C) were measured. *p,0.05, **p,0.01, ***p,0.001 (1way ANOVA). (D) Il-18
-/- mice were
intranasally infected with B. pseudomallei (100 CFU) and their survival monitored. Mice were administered daily injections of PBS or IFNc (1 mg) for the
first 8 days. **p,0.01 (Kaplan-Meier).
doi:10.1371/journal.ppat.1002452.g003
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but decreased in monocytes. Consistent with previously published
results [3], neutrophils did not express NLRC4 mRNA (figure 5B)
suggesting they may be resistant to pyroptosis. Similar results were
obtained using neutrophils and CD11b
+ monocytic cells isolated
from mouse bone marrow (figure 5C). WT monocytes infected
with B. pseudomallei underwent pyroptosis and failed to support
bacteria replication whereas Nlrc4
-/- cells were resistant to
pyropotosis and supported B. pseudomallei intracellular replication.
In contrast, both WT and Nlrc4
-/- neutrophils did not undergo
pyroptosis and supported B. pseudomallei intracellular replication to
the same extent. These results suggest that the deleterious role of
IL-1b during melioidosis may be due, in part, to excessive
recruitment of neutrophils, a cell type that may be permissive for
B. pseudomallei replication. We decided to test this hypothesis in
Nlrc4
-/- mice. As shown in figure 2E, infected Nlrc4
-/- mice showed
a significantly higher degree of lung inflammation. Consistent with
higher neutrophil influx in the lung of Nlrc4
-/- mice, the levels of
the neutrophil enzyme MPO were significantly increased in their
BALF compared to WT mice (figure 6A). To test the hypothesis
that excessive neutrophil influx is deleterious during melioidosis,
Nlrc4
-/- mice were injected with IL-1ra or with antileukinate, a
hexapeptide that acts as a CXCR2 neutrophil chemokine receptor
antagonist. Both factors have been shown to inhibit neutrophil
recruitment to inflammatory sites in different animal models
including lung inflammation [24–26]. As shown in figure 6B,
administration of IL-1ra or antileukinate protected Nlrc4
-/- mice
infected with low doses of B. pseudomallei. The number of
inflammatory cells in the BALF of Nlrc4
-/- mice treated with IL-
1ra or antileukinate was reduced compared to mice who received
Figure 4. Deleterious role of IL-1b in melioidosis. (A) Mice were infected intranasally with B. pseudomallei (200 CFU) and their survival was
monitored. (B) Flow cytometric analysis for myeloid cell composition of BALF obtained from the indicated infected mouse strains at 24 h (left);
infected WT mice injected with IL-1b at 48 h (center graph); or infected WT mice injected with PBS or IL-1ra at 72 h. *p,0.05, ***p,0.001 (1way
ANOVA). (C) Histopathology of lungs of infected mice of indicated genotype (0.8X magnification) at 48 h post-infection (upper row) or WT mice
injected with PBS or IL-1b at 72 hrs post-infection (lower row). Bottom right panel shows 10X magnification of the indicated insets from WT+IL-1b
showing airways obstruction (arrow head) and perivascular edema (asterisks). One image representative of five animals/experimental group. (D) The
total area of the inflammatory nodules of lung sections of C was measured and expressed as percentage of the total lung lobe area. *p,0.05 (t-test).
(E) WT mice were infected intranasally with B. pseudomallei (100 CFU) and received daily i.p. injections of PBS or IL-1b (1 mg). One group of mice were
treated with IL-1b but not infected. **p,0.01, ***p,0.001 (Kaplan-Meyer). (F) Mice infected and IL-1b-injected as in E were sacrificed 72 h post-
infection and the bacterial burden was measured in organs and blood. *p,0.05, **p,0.01 (1way ANOVA). (G) WT mice were infected intranasally with
B. pseudomallei (150 CFU) and were administered daily injections of PBS or IL-1ra. *p,0.05 (Kaplan-Meyer).
doi:10.1371/journal.ppat.1002452.g004
Role of Pyroptosis, IL-18 and IL-1b in Melioidosis
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in the BALF of injected mice (figure S3). Moreover, systemic
spread of bacteria to spleen or liver was reduced by administration
of either drug (figure 6D).
Discussion
The inflammatory response to infection consists of several
protective effector mechanisms that must be activated and
orchestrated in order to maximize microbicidal functions and
stimulation of adaptive immunity while, at the same time,
minimize damage to the host tissues. Alteration in this balance
may result in excessive and non-resolving inflammation that leads
to severe morbidity and mortality [27]. It is becoming clear that to
be effective but non-pathogenic the inflammatory response must
be tailored to each specific pathogen. Here we have analyzed the
role of a very important inflammatory pathway during infection
with the lung pathogen B. pseudomallei. Using a murine model of
melioidosis we have determined the role of various components of
the inflammasome and the downstream effector mechanisms
(production of IL-1b, IL-18, and pyroptosis) and we report several
novel discoveries that greatly increase our understanding of the
pathogenesis of melioidosis (see model in figure 7).
First, we found that both NLRC4 and NLRP3 play non-
redundant roles during detection of B. pseudomallei. Analysis of in
vitro infected macrophages or dendritic cells allowed us to estimate
the relative contribution of NLRC4 and NLRP3 to IL-1b
production. Our findings indicated that production of IL-1b is
primarily dependent on the NLRP3 inflammasome. During the
early phase of the infection the NLRC4 inflammasome also
significantly contributes to IL-1b production. We posit that this
pattern likely reflects the fact that the NLRC4 inflammasome
responds to T3SS deployment, which occurs early in the infection
cycle, while activation of NLRP3 may require escape from the
phagosome, which is a relatively slower event [28]. B. pseudomallei ,
including the strain used in our study, possesses at least three T3SS
Figure 5. Neutrophils do not undergo pyroptosis and fail to restrict B. pseudomallei replication. (A) Human neutrophils or monocytes
were infected with B. pseudomallei (MOI 50) and pyroptosis and intracellular bacterial growth were measured at the indicated time points. One
experiment representative of two is shown. Data are shown as the fold increase normalized to the 2 h values. (B) RT-PCR analysis of total RNA from
the indicated cell types. (C) WT or Nlrc4
-/- mouse neutrophils and monocytic cells were infected with B. pseudomallei (MOI 50) and pyroptosis and
intracellular bacterial growth were measured 8 hours post infection. * p,0.05, **p,0.01, ***p,0.001 (2way ANOVA, post-test Bonferroni).
doi:10.1371/journal.ppat.1002452.g005
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pathogenicity island and has been shown to be an important
virulence factor required for escape from the phagosome,
induction of IL-1b production, and pathogenicity [13,28]. In
addition to mediating host recognition of cytosol-delivered
flagellin, NLRC4 also recognizes a structural motif found in the
basal body rod components of the T3SS of various bacteria,
including B. pseudomallei [29]. We have determined (data not
shown) that transfection of B. pseudomallei flagellin protein into the
cytoplasm of BMDC leads to NLRC4-dependent production of
IL-1b. This result agrees with previously published evidence and
indicates that B. pseudomallei (like some other bacteria) expresses
multiple factors (e.g. flagellin, basal rods) that are recognized by
the NLRC4 inflammasome. The mechanism responsible for
NLRP3 activation by B. pseudomallei remains unclear.
In addition to controlling IL-1b and IL-18 production, NLRC4
also mediates pyroptosis, a form of cell death that is an effective
mechanism to restrict growth and dissemination of intracellular
bacteria [3]. Here we showed that B. pseudomallei-induced
pyroptosis was caspase-1-dependent but ASC-independent, in
agreement with works that showed ASC redundancy for
pyroptosis induced by other bacteria [16–19]. However, the fact
that production of IL-1b in response to B. pseudomallei infection is
seriously compromised in Asc
-/- cells indicates that this adaptor
molecule plays a critical role in NLRC4-mediated cytokine
production and suggests that NLRC4 can form two distinct
inflammasomes: one that contains ASC and regulates IL-1b
processing, and one devoid of ASC that activates caspase-1 and
triggers pyroptosis, as recently proposed [30]. It has been recently
shown [4,5] that NAIP molecules determine the specificity of
NLRC4 for its activators and, we would further speculate, for its
down-stream effector mechanisms. Whether NLRC4 relies on
other molecules to recognize B. pseudomallei remains to be
ascertained. We tested the susceptibility to B. pseudomallei of
Figure 6. Inhibition of neutrophil recruitment to the lung protects Nlrc4
-/- mice from melioidosis. (A) Myeloperoxidase was measured in
BALF of WT and Nlrc4
-/- mice. (B) Nlrc4
-/- mice were infected intranasally with B. pseudomallei (25 CFU) and were administered daily injections of PBS
or IL-1ra (i.p.) or antileukinate (s.c.). **p,0.01, ***p,0.001 (Kaplan-Meyer). (C) Flow cytometric analysis for myeloid cell composition of BALF obtained
from Nlrc4
-/- mice infected and treated with IL-1ra or antileukinate. (D) Nlrc4
-/- mice infected and treated with IL-1ra or antileukinate were sacrificed
48 h post-infection and the bacterial burden was measured in organs. *p,0.05, **p,0.01 (1way ANOVA).
doi:10.1371/journal.ppat.1002452.g006
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A/J/NaJ mice, a consomic C57BL/6 strain that
carries the A/J NAIP5 allele that renders them susceptible to
Legionella infection [31-34], and found that they were indistin-
guishable from WT mice (data not shown).
Analysis of inflammasomes-deficient mice intranasaly infected
with B. pseudomallei confirmed the importance of ASC, caspase-1,
and both NLRP3 and NLRC4 inflammasomes for resistance to
melioidosis. However, quite surprisingly, although production of
IL-1b and IL-18 in vitro is mediated by both NLRP3 and NLRC4,
in vivo it is exclusively dependent on the NLRP3-ASC-caspase-1
inflammasome (figure 2C). In contrast, Nlrc4
-/- mice produce these
cytokines in amounts that exceed even those detected in WT mice.
Remarkably, despite the abundance of IL-1b and IL-18, Nlrc4
-/-
mice were dramatically more susceptible to melioidosis than WT
mice, rapidly succumbed to the infection, and had very high
organ’s bacteria burden and worst neutrophilic lung inflammation.
Thus, the critical role of NLRC4 during melioidosis is indepen-
dent of IL-1b and IL-18 production. Rather, our results suggest
that pyroptosis, which we show is defective in Nlrc4
-/- cells, is a
critical NLRC4 effector mechanism to fight B. pseudomallei and, in
its absence, bacterial replication and IL-1b production proceeds
unrestrained causing severe inflammation, morbidity and mortal-
ity. Moreover, our analysis indicates that pyroptosis and IL-18 are
both required and contribute equally to resistance to melioidosis.
Thus, deficiency of either is equally lethal while deficiency of both
(Casp1
-/- mice) further worsens the outcome. It is important to
emphasize that our study is the first to demonstrate the importance
of pyroptosis in the context of an infection with a clinically relevant
human pathogen that has not been genetically manipulated, as
opposed to the previous seminal work by Miao et al. [3] that
elegantly employed genetically manipulated bacteria and mouse
strains to identify pyroptosis as an effective innate immune defence
mechanism against bacterial infections. Previous reports have
demonstrated activation of both NLRP3 and NLRC4 inflamma-
somes in response to infection with Legionella pneumophila [16],
Listeria monocytogenes [35], and Salmonella typhimurium [36]. However,
in those infection models NLRP3 and NLRC4 appeared to play
redundant roles while in our model we were able to assign distinct
functions to each inflammasome.
A great number of publications have documented the role of IL-
18 and IL-1b during infections with a variety of pathogens. Almost
invariably, both cytokines were found to have a protective
function. Remarkably, our results show that while Il-18
-/- mice
are profoundly vulnerable to melioidosis, as previously shown [37],
Il-1r1
-/- mice were unexpectedly more resistant than WT mice.
The protective role of IL-18 during melioidosis appears to be
related to its ability to induce IFNc, as administration of
exogenous IFNc completely rescued the survival of Il-18
-/-
infected mice. IFNc activates the microbicidal activity of
macrophages and has been shown to be important for resistance
against infection with many pathogens including B. pseudomallei [8–
10]. It is interesting and surprising to see that Asc
-/- and Nlrp3
-/-
mice, which are defective in IL-1b and IL-18 production, are more
resistant to B. pseudomallei than mice lacking IL-18. It is worth
noting that although IL-18 production is drastically reduced in
Asc
-/- and Nlrp3
-/- mice, it is still detectable in these mice at higher
level than uninfected mice. It is conceivable that this inflamma-
some-independent production of IL-18 may be sufficient to
provide some level of protection to Asc
-/- and Nlrp3
-/- mice against
infection with low B. pseudomallei CFU.
Our discovery that Il-1r1
-/- mice were more resistant than WT
to B. pseudomallei infection is quite surprising considering that this
cytokine has been shown to be protective in several bacterial, viral,
and fungal infection models [38]. Studies in humans have also
shown that inhibition of the function of IL-1 using the IL-1R
antagonist IL-1ra (Kineret) is associated with increased suscepti-
bility to bacterial infection. Infected Il-1r1
-/- mice had lower BALF
levels of proinflammatory cytokines as well as a reduction of
neutrophil influx into the lungs, bacterial burdens, and lung
pathology. Consistent with a deleterious role of IL-1b in
melioidosis, administration of recombinant IL-1b drastically
increased mortality, inflammation, pathology, and bacteria
burdens while administration of IL-1ra (Kineret) rescued the
survival of WT mice infected with a lethal dose of B. pseudomallei.
The reason for the detrimental effect of IL-1b during
melioidosis is unclear and it is likely that several factors determine
this outcome. IL-1b is one of the most powerful proinflammatory
cytokines, it affects virtually every organ, and several human
pathologies are primarily driven by unrestrained IL-1b produc-
tion. One possible mechanism to account for IL-1b’s deleterious
role in melioidosis may be related to its ability to inhibit IFNc
production through the induction of the cycloxigenase COX-2
and release of prostaglandin PGE2 [39,40]. Our observation that
the level of IFNc, a protective factor against B. pseudomallei, was
significantly higher in infected Il-1r1
-/- than WT mice (figure 3C)
supports this type of scenario in melioidosis. Interestingly IL-8, a
potent neutrophil chemoattractant, was shown to enhance the
Figure 7. Inflammasomes-dependent protective and deleteri-
ous responses activated by B. pseudomallei. B. pseudomallei
induces NLRC4-dependent pyroptosis that restricts intracellular bacte-
rial growth. Activation of NLRP3-inflammasome leads to production of
IL-18 and IL-1b. IL-18 is protective because of its induction of IFNc. IL-1b
deleterious role may be due to several reasons including excessive
recruitment of neutrophils, which may support intracellular growth of B.
pseudomallei, tissue damage, and inhibition of IFNc production.
doi:10.1371/journal.ppat.1002452.g007
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epithelial cell lines [41]. Whether IL-1b promotes B. pseudomallei
intracellular replication is not known but our preliminary results
indicated that induction of pyroptosis by B. pseudomallei was not
affected by IL-1b.
IL-1b regulates neutrophil recruitment to inflammatory sites
through multiple mechanisms including induction of KC, MIP-2,
and IL-17, inflammatory mediators whose expression in our
experiments correlated with the presence/absence of IL-1RI-
mediated signaling. Excessive PMN recruitment is known to cause
tissue damage leading to functional impairment of multiple organs,
including the lungs [42,43]. One of the most remarkable
observations reported here is that the absence of IL-1 signaling
was associated with reduced lung neutrophilic inflammation but
also lower bacterial burdens in the lungs (figure 3B, 4B).
Conversely, IL-1b administration resulted in increased neutrophil
recruitment but also increased bacterial burdens and systemic
dissemination. These results would be consistent with the idea that
neutrophils are not very effective at containing B. pseudomallei
infection and, in fact, may foster its spread despite their strong
microbicidal activities. This notion is supported by our observation
that human or mouse neutrophils infected with B. pseudomallei
failed to undergo pyropotosis (figure 5), consistent with the finding
that neutrophils do not express NLRC4 [3]. At the same time,
intracellular B. pseudomallei replication proceeded unaffected in
both WT and Nlrc4
-/- neutrophils in agreement with a report that
showed that B. pseudomallei is intrinsically resistant to killing by
infected PMN [44]. In support for a deleterious role of neutrophils
in melioidosis we found that inhibition of their recruitment by
administration of IL-1ra or the CXCR2 neutrophil chemokine
receptor antagonist antileukinate protected Nlrc4
-/- mice from
infection with low doses of B. pseudomallei and decreased systemic
spread of bacteria (figure 6).
Taken together our results suggest the following scenario: failure
of Nlrc4
-/- infected macrophages to undergo pyroptosis results in
higher bacteria burden and continued production of IL-1b and
other factors that attract more inflammatory cells, including
neutrophils, perpetuating excessive lung inflammation and pro-
moting bacteria dissemination. It is tempting to speculate that IL-
1b promotes B. pseudomallei growth possibly by increasing the local
pool of infectable permissive cells, including PMN. Our conclusion
that neutrophils are a permissive cell type for B. pseudomallei
replication seems to contrast with a report [45] that indicated that
depletion of neutrophils resulted in severe increase in mortality in
a model of murine melioidosis. However, caution should be used
in the interpretation of these types of experiments because systemic
depletion of neutrophils devoids the host not only of their
microbicidal function but also of the many immunomodulatory
functions these cells exert [46]. Of note, mice deficient in
osteopontin, a pleiotropic cytokine that is chemotactic for
neutrophils, were shown to be more resistant to B. pseudomallei
infection [47], supporting our conclusion that neutrophils have a
detrimental role in melioidosis.
The notion that excessive inflammation may be detrimental in
certain infection models is well accepted. For example, TLR-
mediated signaling negatively affects the outcome of infections
with West Nile Virus [48] or influenza virus [49]. The fact that IL-
1b is deleterious in melioidosis but protective against other lung
pathogens like Klebsiella, Francisella, Mycobacterium, Respiratory
Syncytial Virus, and influenza virus likely reflects differences
between the virulence strategy of B. pseudomallei and those other
pathogens. The intensity, kinetics, and quality of the inflammatory
response elicited by B. pseudomallei and its ability to suppress the
induction of anti-inflammatory circuitries are phenomena that we
are interested to investigate in detail. Despite an extensive
literature search we could identify only a single report [26] where
IL-1b was shown to be deleterious in bacterial infections. It was
demonstrated that this cytokine had a negative effect on bacterial
clearance in a model of pneumonia caused by Pseudomonas
aeruginosa, an organism that shares features with Burkholderia, which
was in fact previously classified in the Pseudomonas genus.
Surprisingly, the same group also reported a deleterious role for
IL-18 in this type of infection [50], a further indication that each
pathogen displays unique virulence strategies. It has been shown
that activation of the inflammasome exacerbates inflammation
without restricting bacterial growth in a model of Mycobacterial
infection [51]. That report did not examine the role of IL-1b but
other work showed it is protective during tuberculosis [23].
This is the first report that has analyzed in detail the role of the
inflammasome during melioidosis. Previous work has implicated
caspase-1 [52] and IL-18 [37] in this infectious disease although
the pathways that led to their activation were not investigated.
Other species of Burkholderia have been used as model organisms to
study aspects of inflammasome biology. Surprisingly, B. thailan-
densis, which is has been used as a model for melioidosis although it
rarely causes disease in humans, was reported to cause similar
disease in WT and IL-18- IL-1b-double deficient mice [3]
suggesting that species of Burkholderia other than B. pseudomallei
may not be reliable models for melioidosis.
In summary, our work shows that NLRP3 and NLRC4 play
non-redundant roles during B. pseudomallei infection by differen-
tially regulating pyroptosis and production of IL-1b and IL-18; it
demonstrates that pyroptosis is an efficient effector mechanism to
restrict in vivo bacterial growth and dissemination; it identifies a
deleterious role of IL-1b in melioidosis possibly due to excessive
recruitment of neutrophils, a cell type that may be permissive to
replication of B. pseudomallei; and, finally, it indicates that inhibition
of IL-1RI-mediated signaling may be a beneficial therapeutical
approach for the treatment of melioidosis.
Materials and Methods
Ethics statement
All the animal experiments described in the present study were
conducted in strict accordance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National
Institutes of Health. All animal studies were conducted under a
protocol approved by the University of Tennessee Health Science
Center (UTHSC) Institutional Animal Care and Use Committee
(IACUC, protocol #1854). All efforts were made to minimize
suffering and ensure the highest ethical and humane standards.
Research involving human blood is exempt from the human
subjects regulations. Human neutrophils and monocytes were
isolated from healthy donors Leukopacks obtained from Lifeblood
Mid-South Regional Blood Center, Memphis TN. All leukopaks
are obtained anonymously. The gender, race, and age of each






were purchased from Jackson lab. Il-18
-/--Il-1r1
-/- double deficient




-/- (from Vishva Dixit, Genentec)
and Casp1
-/- (from Fayyaz Sutterwala) were bred in our facility. All
mouse strains were on C57BL/6 genetic background and were
bred under specific pathogen-free conditions. Age-(8–12 weeks
old) and sex-matched animals were used in all experiments.
Generally, experimental groups were composed of at least 5 mice.
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performed under biosafety level 3 conditions in accordance with
standard operating procedures approved by the Regional
Biocontainment Laboratory at UTHSC.
Bacteria, mice infection, and treatments
For all experiment the B. pseudomallei 1026b strain (a clinical
virulent isolate) was used. Bacteria were grown in Luria broth
(Difco) to mid-logarithmic phase, their titer was determined by
plating serial dilutions on LB agar, and stocks were maintained
frozen at 280uC in 20% glycerol. No loss in viability was observed
over prolonged storage. For infections, frozen stocks were diluted
in sterile PBS to the desired titer. Aliquots were plated on LB agar
to confirm actual CFU. Mice were anesthetized with isoflurane
using a Surgivet apparatus and 50 ml of bacteria suspension were
applied to the nares. In some experiments, mice were injected i.p.
daily with recombinant mouse IL-1b (1 mg) or IFNc (1 mg). IL-1ra
(Biovitrum) was administered by alternating s.c. and i.p. injections
every 12 hours (60 mg/kg body weight). Antileukinate (American
Peptide Company) was administered by s.c. injection (8 mg/kg
body weight).
Generation of mouse BMDM and BMDC
Mouse macrophages or dendritic cells were generated by
incubating bone marrow cells in RPMI 1640-10%FCS supple-
mented with either rmM-CSF or rmGM-CSF (20 ng/ml) for 8
days, respectively.
Isolation of mouse neutrophils
Neutrophils and monocytic cells were isolated from the bone
marrow cells of WT or Nlrc4
-/- mice using Miltenyi Ly6G
microbeads. Flow-through cells, consisting mostly of monocytic
cells, were further purified using Miltenyi CD11b microbeads.
Isolation of human neutrophils and monocytes
Human neutrophils and monocytes were isolated from healthy
donors Leukopacks obtained from Lifeblood Mid-South Regional
Blood Center, Memphis TN. Blood was mixed with Isolymph
(CTL Scientific Supply Corp.) (5:1 ratio) and RBC were allowed to
sediment for 60 min at RT. The leukocytes-enriched supernatant
was washed, resuspended in PBS, and stratified over Isolymph
cushion and centrifuged at 1,350 rpm for 40 min. The cell pellet
containing RBC and neutrophils was treated with 0.2% NaCl for
30 seconds to lyse RBC and immediatedly treated with an equal
volume of 1.6% NaCl. The PBMC containing ring from the
Isolymph centrifugation step was collected, washed, and mono-
cytes were purified using CD14 microbeads (Miltenyi). The
procedure routinely yield populations of purity greater than 95%.
Pyroptosis and intracellular bacteria growth (kanamycin
protection assay)
Release of LDH in tissue culture media, a reflection of
pyroptosis, was measured using the Roche Cytotox detection kit.
BMDM, PMN, or monocytes (5610
5 cells) were plated in 24 well
plates. Bacteria at different MOI were added to the cell culture
and the plates were centrifuged at 1500 rpm for 10 minutes to
maximize and synchronize infection and incubated for 30 minutes
at 37uC. Cells were washed with PBS to remove extracellular
bacteria and medium containing kanamycin (200 mg/ml) was
added to inhibit extracellular bacteria growth. Media were
collected at 1, 2, 4, 8, 12 hours post infection for LDH
measurement. Cells were lysed in PBS-2% saponin-15% BSA
and serial dilutions of the lysates were plated on LB agar plates
containing streptomycin (100 mg/ml) using the Eddy Jet Spiral
Plater (Neutec). Bacterial colonies were counted 48 hours later
using the Flash & Grow Automated Bacterial Colony Counter
(Neutec).
Determination of bacteria growth in tissue culture and
organs
Organs aseptically collected were weighted and homogenized in
1 ml PBS using 1 mm zirconium beads and the Mini16 bead
beater. Serial dilutions were plated as described above.
Western blot
Conditioned supernatants were separated by 12% PAGE
electrophoresis, transferred to PVDF membranes, and probed
with rabbit anti-caspase-1 (Upstate Biotechnologies) or goat anti-
mIL-1b (R&D Systems).
BALF collection and cytokines measurements
BALF were collected from euthanized mice by intratracheal
injection and aspiration of 1 ml PBS. Cytokines levels in tissue
culture conditioned supernatants and BALF were measured using
the Milliplex mouse cytokine/chemokine panel (Millipore) and
confirmed by ELISA using the following paired antibodies kits:
mIL-1b and mIFNc (eBioscience), mIL-18 (MBL Nagoya, Japan).
MPO level in BALF were measured using the HyCult Biotech
ELISA kit.
Flow cytometry
Cells obtained from BALF were counted and stained with
CD45, CD11b, CD11c, F4/80, GR1 (Ly6G), and analyzed with a
LSRII BD flow cytometer.
Histology and measurement of area of inflammatory foci
Formalin-fixed paraffin-embedded lung sections were stained
with H&E and scanned using the Aperio Scanscope XT. The
Aperio ImageScope software was used to quantitate the area of the
inflammatory foci compared to the total lung lobe area. Results
from lungs from 5 animals per group were combined.
RT-PCR
Total RNA was extracted using Trizol (Invitrogen) and 100 ng
were amplified (27 cycles) using Superscript III One-step RT-PCR
(Invitrogen) and primers specific for human Nlrc4, Nlrp3, Asc, and
GAPDH (primers’ sequence available upon request).
Statistical analysis
All data were expressed as mean 6 S.E.M. Survival curves were
compared using the log rank Kaplan-Meier test. 1way ANOVA
and Tukey Post-test was used for analysis of the rest of data unless
specified in the figure legends. Significance was set at p,0.05.
Statistical analyses were performed using the GraphPad Prism 5.0.
Accession numbers
UniProtKB/Swiss-Prot ID: IL-1b, P10749; IL-1R1, P13504;
IL-18, P70380; NLRP3, Q8R4B8; NLRC4, Q3UP24; ASC,
Q9EPB4; Casp-1, P29452; NAIP5, Q8CGT2.
Supporting Information
Figure S1 NLRP3 and NLRC4 differentially regulate
production of IL-1b and IL-18 and pyroptosis. BMDC
were infected with B. pseudomallei at MOI of 10. (A) Secretion of
mature IL-1b was measured in conditioned supernatants at the
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detected by immunoblot in 8h conditioned supernatants from A.
(C) BMDC infected with B. pseudomallei (MOI 10) were lysed at the
indicated time points after infection and intracellular bacterial
growth was quantitated (upper panel). Induction of pyroptosis was
measured as LDH release in conditioned supernatants (lower
panel). One experiment representative of four (A) or three (C) is
shown. *p,0.05, **p,0.01, ***p,0.001 (1way ANOVA).
(TIF)
Figure S2 Cytokines and chemokines were measured in
BALF obtained from the indicated mouse strains 48
hours or 72 hours post-infection, as shown. *p,0.05,
**p,0.01, ***p,0.001 (1way ANOVA).
(TIF)
Figure S3 Myeloperoxidase (MPO) was measured in
BALF of the indicated mouse strains corresponding to
the experiments of figures 3B, 4F, and 6D. *p,0.05,
**p,0.01, ***p,0.001 (1way ANOVA).
(TIF)
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